Detemir
Sponsors
The Royal Bournemouth Hospital, Diabetes Care Center, University Hospital Tuebingen, Eli Lilly and Company, University of Calgary
Conditions
Cardiovascular DiseaseDiabetesDiabetes MellitusDiabetes Mellitus Type 1Diabetes Mellitus Type 2Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Endothelial Dysfunction
Phase 3
Phase 4
Hospital In-Patient Insulin Study
TerminatedNCT00135070
Start: 2005-07-31End: 2006-06-30Updated: 2007-05-01
Hypoglycemia Counterregulation and Symptom Perception With Insulin Detemir
TerminatedNCT00490893
Start: 2006-03-31End: 2006-12-31Updated: 2007-06-25
Endothelial Effects of Basal Insulin: Detemir Versus Glargine
CompletedNCT00699686
Start: 2008-05-31End: 2010-03-31Target: 50Updated: 2010-08-17
Transitioning Open Heart Surgery Patients From Insulin Infusions to Detemir
CompletedNCT00717288
Start: 2008-07-31End: 2010-06-30Updated: 2011-10-03
Detemir Energy Expenditure Study
CompletedNCT00788840
Start: 2008-01-31End: 2009-08-31Updated: 2023-05-31
Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis
NCT01271517
Start: 2005-09-30Updated: 2011-01-06
The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study
CompletedNCT01966978
Start: 2014-11-30End: 2017-12-31Updated: 2019-10-22
Unknown Phase
A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes
CompletedNCT00457093
Start: 2006-10-31End: 2007-05-31Target: 35Updated: 2010-11-18
Comparison of a Twice Daily Versus a Three Times Daily Insulin Regimen in Children With Type 1 Diabetes
CompletedNCT00522210
Start: 2008-03-31End: 2011-03-31Updated: 2014-09-03
Effectiveness of Adding Subcutaneous Long-Acting Detemir to Insulin Drip Therapy Compared With Standard Insulin Drip Therapy
CompletedNCT01186003
Start: 2010-08-31End: 2014-05-31Updated: 2021-12-07
Insulin Detemir in Obesity Management
Active, not recruitingNCT01239550
Start: 2011-04-01End: 2028-12-01Target: 240Updated: 2026-01-23